Introducing the two newest JLABS EMEA companies - Pepticom Ltd and Vector BioSciences. Visit our website to learn more about their work and their mission. jji.jnj/4fWmxcN

What does it take to create a space that allows innovators to change the healthcare industry? A strong foundation. Our JLABS San Diego recently held a JMIX event to build connections between leaders in the life science ecosystem. Here's how it went: jji.jnj/4mVRqRn

The deadline is approaching - submit your novel ideas aimed at transforming treatment & care for patients with Bladder & Prostate Cancers October 3. Learn more here: jji.jnj/UUOI25

The future of Alzheimer's research, lung cancer treatment decisions, Australia's world-class healthcare infrastructure, and exciting developments in Europe. You can find it all in the latest edition of our innovation newsletter here. jji.jnj/2PCz39A

JLABS can help incubate top emerging companies developing intratumoral approaches if they are in J&J areas of interest. Register for this exciting event in Basel or Munich to find out more!

Finish the sentence: A JPAL is… Meet our team here: jji.jnj/4mY60aH

Early-stage innovators and emerging companies based in the UK’s life sciences Golden Triangle! Are you working in an area of interest to Johnson & Johnson? Register now for our Life Sciences Innovation Evening with J&J at our London Innovation Centre on 29 Sept.

Innovators, academics, and portfolio managers – the deadline to apply to meet with Johnson & Johnson experts in Interventional Oncology & Oncology in Basel is 7 October.

Entering the healthcare industry as a startup can be intimidating. Which is why we created our JPALS program to help our resident and member companies reach success every step of their journey from inception to development. jji.jnj/4mY60aH

Innovators, academics, and portfolio managers – the deadline to apply to meet with Johnson & Johnson experts in Interventional Oncology & Oncology in Munich is 7 October. Don’t miss out!

A chance encounter brought the founder of JLABS resident company LivAi together with a tech leader, and together, they are using AI to change the way we approach imaging in oncology. Read more here: jji.jnj/46ZF30K

Thank you to all who attended our Life Sciences Innovation Evening. To hear about future events and updates, subscribe to our mailing list. jji.jnj/2PCz39A

We want to introduce you to someone. Actually, a few 'someone''s. These are the bright, smart, driven people behind our JPALS program, who are ready and waiting to help our JLABS members and residents achieve their goals. jji.jnj/4mY60aH

The deadline is approaching to submit novel ideas addressing AI in drug development. Apply to pitch your innovation before October 13. jji.jnj/pitchAI

We sat down with the founder of LivAi - JLABS San Francisco's newest resident company - to learn more about their mission, and how they're using AI to transform imaging in oncology while giving clarity to patients. Read more: jji.jnj/46ZF30K

Catch us if you can: sign up for the latest edition of our Innovation newsletter to see where we’ll be for the remainder of 2025, and what opportunities to collaborate and connect are coming up. Subscribe here: jji.jnj/2PCz39A

The Pitching Critical Assessment for Therapeutic Protein Design (CAT-PD) QuickFire Challenge is live! Submit your innovations with the potential to help advance drug discovery using de novo therapeutic protein design. Apply by November 21. jji.jnj/CATPD

We'd like to introduce you to the newest members of our community who are making a splash in the Asia Pacific region. We're excited to see what they accomplish in the coming months to help pioneer healthcare solutions: jji.jnj/4n6VI7L

What lies ahead for the 4 member companies from our Asia Pacific region who were selected to be a part of Forbes Asia Magazine’s 100 to Watch 2025 list? Click here to find out. jnjinnovation.com/news/blog-post…

We are Johnson & Johnson's global incubation network that provides startups with resources, industry connections, community, lab space, & whatever else they need to succeed. Lean more about our residency types: jji.jnj/47plVJP